Skip to main content
Dryad

Healthy and B-cell precursor Acute Lymphoblastic Leukemia (ALL) cells analyzed via CyTOF

Abstract

This is a dataset of 1,108,853 blood and bone marrow cells collected from 3 pediatric B-cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) patients and 3 healthy controls. Each ALL sample is made up of a mixture of cancer cells and healthy cells, whereas the healthy samples do not contain and cancer cells. This dataset can be used to evaluate models trained to classify cells as either cancerous or non-cancerous. 

Each BCP-ALL patient has samples collected from 3 timepoints and 2 tissues: diagnosis (bone marrow and blood), day 8 post-treatment initiation with chemotherapy (blood), and day 15 post-treatment initiation (blood). Healthy patients only have samples collected from a single timepoint (the time of donation) and one tissue (bone marrow). These different tissues and timepoints can be used to assess a classifier's ability to generalize to new contexts (i.e. from bone marrow to blood, or from the diagnostic timepoint to a timepoint later in treatment).